BioHeart

^{, Nasdaq: BHRT}

A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.

Industry: Health Care

First Day Return: -4.8%

BHRT

A biotechnology company focused on using cells derived from a patient's body for treatment of heart damage.

IPO News for BioHeart

Seattle-based biotech Omeros sets IPO terms 09/16/09
Biotech company BioHeart prices at midpoint of revised range 02/19/08
Biotech company BioHeart amends IPO terms 02/13/08

IPO Data
IPO Date	02/18/2008
Offer Price	IPO Intelligence Only
Price Range	IPO Intelligence Only
Offer Shares (mm)	IPO Intelligence Only
Deal Size ($mm)	$6
Lock-Up Date	IPO Intelligence Only
Street Research	IPO Intelligence Only

Underwriters
IPO Intelligence Only

Company Data
Website www.bioheartinc.com
Headquarters	Sunrise, FL, United States
Founded	1999
Employees at IPO	22

IPO News for BioHeart

Seattle-based biotech Omeros sets IPO terms 09/16/09
Biotech company BioHeart prices at midpoint of revised range 02/19/08
Biotech company BioHeart amends IPO terms 02/13/08

BioHeart (BHRT) Performance